## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.8% below STRENGTH zone (3.0-6.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($304.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. What You Need To Know Ahead of Chubbâ€™s Earnings Release**
- Source: Barchart.com | 20251224T143514 | Somewhat-Bullish | Relevance: 100%
- Chubb Limited (CB) is set to release its Q4 fiscal 2025 earnings, with analysts projecting a 5.2% year-over-year increase in diluted EPS to $6.33. Despite a history of beating estimates and optimistic full-year EPS growth forecasts of 5.2% to $23.67 for 2025, Chubb's stock has underperformed both the broader S&P 500 and the financial sector ETF (XLF) over the past year. Analysts maintain a "Moderate Buy" consensus rating for CB, with a mean price target close to current levels, but a high target suggesting 16.2% upside.

**2. Chubb Limited Appoints John Depeters as Executive Vice President, Head of Commercial Insurance and Specialty**
- Source: marketscreener.com | 20251223T203845 | Somewhat-Bullish | Relevance: 100%
- Chubb Limited has appointed John DePeters as Executive Vice President, Head of Commercial Insurance and Specialty for Chubb Overseas General Insurance (COG). Mr. DePeters, who has over 13 years of insurance experience, will be based in London. This new role will see him leading the commercial and specialty insurance operations for COG.

**3. People Moves: Chubb Overseas General Promotes DePeters to Lead Commercial Insurance, Specialty; BMS Taps Emkes From Lockton as Director of Commercial D&O**
- Source: Insurance Journal | 20251222T160728 | Bullish | Relevance: 100%
- Chubb Overseas General Insurance has appointed John DePeters as executive vice president, head of Commercial Insurance and Specialty, effective January 1, 2026. In another move, BMS, the independent insurance and reinsurance broker, announced the appointment of Charlie Emkes as director of commercial directors and officers (D&O) solutions, effective from January 2026. Emkes joins from Lockton with over 12 years of experience in the London Market.

**4. Planned Chubb AI overhaul places 20% of jobs at risk**
- Source: Insurance Times | 20251224T072719 | Somewhat-Bearish | Relevance: 100%
- Chubb plans to cut approximately 20% of its global workforce, impacting 8,500 to 9,000 roles, over the next three to four years as part of a major digital transformation focused on AI and automation. This initiative aims to automate 85% of major underwriting and claims processes and generate 85% of global gross written premium digitally, positioning the insurer for an anticipated soft market. The company also projects its private investments to grow from $0.9bn to around $2bn.

**5. Shikiar Asset Management Inc. Has $3.29 Million Position in Chubb Limited $CB**
- Source: MarketBeat | 20251223T130747 | Somewhat-Bullish | Relevance: 100%
- Shikiar Asset Management Inc. significantly reduced its stake in Chubb Limited by 48.0% in Q3, now holding 11,640 shares valued at approximately $3.29 million. Despite this, Chubb reported strong quarterly earnings, surpassing analyst expectations, and announced a quarterly dividend, while institutional investors collectively own 83.81% of the stock. Analysts currently maintain a consensus "Hold" rating for Chubb with a target price of $311.90.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $318 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($14.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Heavy insider selling: $15M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $124.9B |
| Beta | 0.52 |
| 52W Range | $252.16 - $314.40 |
| Short Interest | 0.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 11.9 |
| Current P/E | 13.2 |
| YoY Growth | 11.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 3.3% to -0.8% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.8pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.78% (CS: 54) | Neutral |
| RSI_14 | 69.9 | Neutral |
| MACD Histogram | 0.46 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.072x | Above |
| vs SMA200 | 1.099x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $313.26
- **Stop Loss:** $304.74 (2.7% risk)
- **Target:** $321.78 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 169
- **Position Value:** $52,940.94
- **Portfolio %:** 52.94%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*